APLNR and heart failure: In this aspect, the apelin–APJ system is attractive because it appears to be downregulated in heart failure (Japp and Newby, 2008), and stimulation of this pathway may have additive or even synergistic efficacy to current therapy by targeting complementary but separate pathways.